Work

Abstract LB223: Discovery of INV-6452, a CDK2/4 inhibitor for the treatment of HR-positive HER2-negative breast cancer resistant to current CDK4/6 therapy

Year: 2025

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2025-lb223

Authors: Chang Bai, Nansong Xia, Yexing Cao, Shujuan Huang, Danqi Chen, Hongjian Yang, Lishan Lin, Zhaopie Zeng, Jing Su, Yongkui Sun

Language: English

Topic: Advanced Breast Cancer Therapies

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409821394

Cites:

Cited by: 2

Related to: 10